查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676944

经颈静脉经子宫颈门静脉分流术市场按产品类型、程序类型、材料类型、应用和最终用户划分 - 2025 年至 2030 年全球预测

Transjugular Intrahepatic Portosystemic Shunt Market by Product Type, Procedure Type, Material Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年经子宫颈肝内门体分流术市场价值为 1.0255 亿美元，预计 2025 年将成长至 1.0678 亿美元，复合年增长率为 4.27%，预计到 2030 年将达到 1.3181 亿美元。

主要市场统计数据
基准年 2024 年 1.0255亿美元
预计 2025 年 1.0678亿美元
预测年份 2030 1.3181亿美元
复合年增长率（%） 4.27％

经子宫颈肝内门静脉分流术（TIPS）是治疗门静脉高压及其相关併发症的重要治疗方法。这份全面的执行摘要深入探讨了 TIPS 市场的复杂动态，详细介绍了推动成长和改变患者治疗结果的技术创新、不断发展的程序和策略市场细分。

在医疗水准快速进步的今天，TIPS作为缓解肝硬化、门脉高压、布加症候群等併发症的极其重要的治疗方法而备受关注。除了临床成功之外，对病人安全和术后护理的日益重视也引起了从医院到专科诊所等广泛终端使用者的兴趣。随着监管环境的不断发展和新型医疗设备治疗效果的提高，相关人员正在努力应对严峻的市场挑战，这些挑战不仅与临床试验和产品创新有关，还与竞争动态和成本限制有关。

本摘要详细介绍了 TIPS 市场内的变革性变化、揭示关键产业趋势的严格细分方法，以及为寻求持续市场成功的产业领导者提供的策略建议。在定性和定量洞察的支持下，分析已成为快速发展的医疗保健模式中策略决策的基础。

经子宫颈静脉肝内门体分流术市场的转型

在过去的十年中，TIPS格局发生了变革，重新定义了市场结构和价值提案。有几个关键因素推动了这一演变。

一个关键的改变是技术创新步伐加快。专为 TIPS 设计的医疗设备现在拥有先进的功能，可提高分流器放置的准确性并改善患者的治疗效果。这项进展得到了新研究的补充，检验了临床效果，增强了医生和患者的信心。从球囊扩张器到导管到导丝，辅助设备的发展使得手术程序变得现代化，从而使得手术更加顺利，并降低了手术风险。

同时，为了跟上这些技术创新，各大厂商和科研机构都在积极投入研发。监管机构也在调整指导方针，以支持引入创新治疗方法，同时确保安全性和合规性。这些进步的政策，加上许多地区的市场自由化，为相关人员探索新的临床应用和工艺改进提供了充足的机会。

另一个变革力量是临床资料与商业主导洞察的融合。治疗机构越来越多地使用真实世界证据来改进产品开发和改善患者通讯协定，推动从传统治疗方法转向更全面的、技术支援的方法的转变。这种资料主导的洞察力和创新产品的结合正在改变竞争格局，并促进设备製造商、医疗保健提供者和研究机构之间的合作和策略联盟。

本质上，市场不仅正在经历从传统程序技术向最尖端科技整合的显着转变，而且还正在经历向更加以患者为中心的转变。有效利用这些动态的行业参与者将能够推动未来市场成长，同时改善不同患者群体的临床结果。

TIPS 市场的关键细分洞察

TIPS 市场的細項分析提供了多层次的观点，可协助产业相关人员识别成长机会并了解市场多样化。根据产品类型，市场主要分为配件和支架。在附属设备领域，球囊扩张器、导管和导丝等组件受到严格审查，它们每个都在提高手术准确性和患者安全性方面发挥着至关重要的作用。相较之下，支架类别分为裸金属支架、药物释放型支架和分段支架，突显了针对特定临床场景的材料和设计的演变。

根据手术类型，我们检查选择性分流术和紧急分流术。紧急分流器通常需要快速部署且不影响功效，重点在于简化协定并确保设备在时间敏感的情况下的可靠性。另一方面，在选择性分流术中，规划和计算方法已经得到更广泛的发展，可以根据个别患者的需求制定干预措施。

金属支架以其耐用性和长期性能而闻名，而聚合物支架则具有灵活性和成本效益，两者之间存在明显的差异。每种材料类型都有不同的临床益处和风险状况，这将影响市场采用和定价策略。

此外，对应用领域的分析表明，该市场旨在满足各种与肝臟相关的健康状况。布德-加氏症候群、C型肝炎、肝硬化和门脉高压等疾病反映了 TIPS 手术治疗的多功能性，但也凸显了治疗这些复杂疾病的挑战。最后，基于最终用户细分的评估显示范围广泛，包括门诊手术中心、医院、研究机构和专科诊所。这种分布凸显了TIPS程式在各种医疗保健基础设施中的广泛接受度和实用性，进一步增强了市场需求并刺激了整个设备类别的创新。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 肝硬化、门脉高压等肝病发生率增加
      • 由于恢復时间缩短，微创手术的采用率增加
    • 限制因素
      • 肝内门体分流术的安全性问题和潜在併发症
    • 机会
      • 使用人工智慧制定个人化的 TIPS 治疗计划以改善患者治疗效果
      • 利用材料技术进步提高 TIPS 设备的有效性和安全性
    • 任务
      • 与 TIPS 程序相关的保险覆盖不足和报销问题
  • 市场区隔分析
    • 产品类型：微创手术辅助设备需求不断成长
    • 应用：门脉高压治疗中对TIPS手术的需求日益增加
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章经子宫颈肝内门静脉分流术市场（依产品类型）

  • 附属设备
    • 球囊扩张器
    • 导管
    • 导管导引线
  • 支架
    • 裸金属支架
    • 药物释放型支架
    • 分段支架

第七章经子宫颈肝内门静脉分流术市场（依手术类型）

  • 选择性分流
  • 紧急分流

第 8 章经子宫颈肝内门静脉分流术市场（依材料类型）

  • 金属支架
  • 聚合物

经子宫颈肝内门静脉分流术市场（依应用）

  • 布加氏症候群
  • C型肝炎
  • 肝硬化
  • 门脉高压症

第 10 章经子宫颈肝内门静脉分流术市场（依最终使用者）

  • 门诊手术中心
  • 医院
  • 研究组织
  • 专科门诊

11. 美洲经子宫颈肝内门静脉分流术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区经子宫颈肝内门静脉分流术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲经颈经子宫颈肝内门静脉分流术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • AngioDynamics Inc.
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Medtronic
  • Merit Medical Systems, Inc.
  • Siemens Healthcare Limited
  • Sirtex Medical Inc.
  • Terumo Medical Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-562E923A956A

The Transjugular Intrahepatic Portosystemic Shunt Market was valued at USD 102.55 million in 2024 and is projected to grow to USD 106.78 million in 2025, with a CAGR of 4.27%, reaching USD 131.81 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 102.55 million
Estimated Year [2025] USD 106.78 million
Forecast Year [2030] USD 131.81 million
CAGR (%) 4.27%

The transjugular intrahepatic portosystemic shunt (TIPS) represents a critical intervention in the management of portal hypertension and its ensuing complications. This comprehensive executive summary delves into the complex dynamics of the TIPS market, detailing the technological innovations, evolving procedural techniques, and strategic market segmentation that drive growth and transform patient care outcomes.

In today's era of rapid medical advancement, TIPS procedures have emerged as a pivotal treatment option particularly aimed at alleviating complications associated with liver cirrhosis, portal hypertension, and conditions like Budd-Chiari Syndrome. Clinical successes combined with heightened emphasis on patient safety and post-procedure care have bolstered interest across a range of end-users from hospitals to specialty clinics. As regulatory landscapes continue to evolve and novel medical devices enhance the intervention's efficacy, stakeholders find themselves navigating not only clinical trials and product innovation but formidable market challenges tied to competitive dynamics and cost-constraints.

This summary provides an in-depth look at the transformative shifts within the TIPS market, rigorous segmentation approaches that illuminate key industry trends, and strategic recommendations designed for industry leaders targeting sustained market success. The analysis supported by qualitative and quantitative insights sets a foundation that underpins strategic decision-making in a rapidly evolving healthcare paradigm.

Transformative Shifts in the TIPS Market Landscape

Over the past decade, the TIPS landscape has undergone transformative shifts that have redefined the market's structure and value proposition. Several key factors are driving this evolution.

One significant shift is the accelerated pace of technological innovation. Medical devices specifically designed for TIPS now boast advanced features, greater precision in shunt placement, and improved patient outcomes. This evolution is complemented by new research studies that validate clinical efficacy, driving confidence among both practitioners and patients. The development of accessory devices-ranging from balloon expanders to catheters and guiding wires-has modernized procedural techniques, enabling smoother operations and reduced operative risks.

Concurrently, these innovations have been met with rigorous reinvestments in research and development driven by leading manufacturers and research institutes alike. Regulatory bodies are also adapting their guidelines to support the introduction of innovative therapies while ensuring safety and compliance. These forward-thinking policies, coupled with market liberalization in many regions, have provided ample opportunity for stakeholders to explore new clinical applications and process improvements.

Another transformative force is the merging of clinical data with commercially driven insights. Institutions are increasingly leveraging real-world evidence to refine product development and improve patient protocols, catalyzing a shift from traditional treatment modalities to more integrated, technology-enhanced approaches. This blend of data-driven insights and innovative product offerings has reshaped the competitive landscape, inviting collaboration and strategic alliances among device manufacturers, healthcare providers, and research agencies.

In essence, the market is experiencing a notable shift not only from conventional procedural methods to cutting-edge technological integration but also towards a more patient-centric approach. Industry players who effectively harness these dynamics are well positioned to drive future market growth while enhancing clinical outcomes for a diverse patient demographic.

Key Segmentation Insights in the TIPS Market

The segmentation analysis of the TIPS market provides a multi-layered view that assists industry stakeholders in identifying growth opportunities and understanding market diversification. In reviewing product type, the market is predominantly divided between accessory devices and stents. The segment for accessory devices is meticulously examined to include components such as balloon expanders, catheters, and guiding wires, each of which plays a vital role in improving procedural accuracy and patient safety. In contrast, the stent category is further nuanced into bare metal stents, drug-eluting stents, and sectional stents, highlighting the evolution of materials and design tailored to specific clinical scenarios.

A separate segmentation perspective is offered by procedure type, where both elective and emergency shunts are scrutinized. Recognizing that emergency shunts often require rapid deployment without compromising efficacy, there has been an emphasis on streamlining protocols and ensuring device reliability under time-sensitive conditions. This is balanced with elective shunts where the planning and computational methodologies are more extensively developed to tailor interventions to individual patient needs.

Material type segmentation also provides intriguing insights into the market's progression, with a clear division between metallic stents, known for their durability and long-term performance, and polymer-based solutions that offer flexibility and cost-effectiveness. Each material type demonstrates differing clinical benefits and risk profiles, which in turn influence market adoption and pricing strategies.

Moreover, analysing the application segment reveals that the market is designed to address a wide spectrum of liver-related health conditions. Conditions such as Budd-Chiari Syndrome, Hepatitis C, liver cirrhosis, and portal hypertension not only reflect the therapeutic versatility of TIPS procedures but also underscore the challenges in managing these complex diseases. Finally, evaluation based on end-user segments indicates a diverse range that includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. The distribution underscores the widespread acceptance and utility of TIPS procedures across various healthcare infrastructures, further bolstering market demand and encouraging innovation across device classes.

Based on Product Type, market is studied across Accessory Devices and Stents. The Accessory Devices is further studied across Balloon Expanders, Catheters, and Guiding Wires. The Stents is further studied across Bare Metal Stents, Drug-Eluting Stents, and Sectional Stents.

Based on Procedure Type, market is studied across Elective Shunts and Emergency Shunts.

Based on Material Type, market is studied across Metallic Stents and Polymers.

Based on Application, market is studied across Budd-Chiari Syndrome, Hepatitis C, Liver Cirrhosis, and Portal Hypertension.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Research Institutes, and Specialty Clinics.

Regional Insights and Market Penetration Trends

An examination of regional trends reveals a multifaceted market with distinct growth patterns across geographies. The Americas have exhibited robust market growth driven by high healthcare spending, advanced clinical infrastructure, and strong research investments. There is significant adoption of TIPS procedures in this region, supported by a well-coordinated network of tertiary care centers and a proactive regulatory environment that facilitates innovation.

In the Europe, Middle East & Africa region, market dynamics are influenced by a combination of mature healthcare frameworks in developed European countries and evolving infrastructure in various MEA nations. Here, incremental investments in healthcare technology have enhanced the operational efficiency of TIPS procedures, while cross-border collaborations and knowledge-sharing initiatives are fostering greater clinical confidence.

The Asia-Pacific region is emerging as a critical growth driver for the TIPS market. Rapid urbanization, improving healthcare facilities, and increased access to cutting-edge medical interventions are fueling demand in this region. Local and international manufacturers are keenly tuning into the region's vast potential by customizing their product offerings to suit the demographic and clinical idiosyncrasies particular to diverse markets in Asia-Pacific. Collectively, these regional variations offer valuable insights that can assist market participants in tailoring their approaches to meet localized needs and drive sustained market penetration.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Strategic Insights into Leading Industry Players

A competitive analysis of the TIPS market underscores the presence of major players with significant influence over technological and clinical advancements in the field. Companies such as AngioDynamics Inc. and Argon Medical Devices, Inc. are at the forefront of driving product innovations, particularly in designing state-of-the-art accessory devices and advanced stent solutions. Their focus on developing balloon expanders, catheters, and guiding wires continues to set industry benchmarks for procedural efficiency and safety.

Becton, Dickinson and Company and Boston Scientific Corporation have harnessed their extensive research capabilities to introduce breakthrough technologies that enhance device performance while optimizing cost efficiency. The rigorous R&D efforts spearheaded by leaders like Cook Group Incorporated and Medtronic have been pivotal in ensuring that clinical outcomes are both safe and reproducible.

Merit Medical Systems, Inc. along with Siemens Healthcare Limited, have contributed to streamlining manufacturing processes, further refining the precision of TIPS-related devices. Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc. have also carved niche yet decisive market segments by focusing on specific device innovations tailored to meet varied clinical requirements.

The strategic interplay among these top companies is fostering a competitive yet collaborative environment in the market. Their continuous improvements in device design, coupled with advancements in procedural technology, create immense value for healthcare providers. This, in turn, ensures that patient outcomes remain at the core of innovation, thereby delivering a blend of operational excellence and clinical safety that sustains industry growth over time.

The report delves into recent significant developments in the Transjugular Intrahepatic Portosystemic Shunt Market, highlighting leading vendors and their innovative profiles. These include AngioDynamics Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Medtronic, Merit Medical Systems, Inc., Siemens Healthcare Limited, Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Growing Market Leaders

Industry leaders looking to secure a competitive edge in the TIPS market should embrace a multi-pronged strategy that promotes innovation, operational efficiency, and market adaptability. A primary recommendation is to advance research and development initiatives not only in terms of hardware-such as improving the design of accessory devices and stents-but also in integrating digital health technologies that allow for real-time data monitoring and outcomes analysis. Collaboration between surgeons, researchers, and technologists can pave the way for developing devices that are adaptable to both elective and emergency procedural demands.

Another essential strategy involves expanding the geographical footprint by tailoring device solutions to the unique needs of various regions. Understanding local regulatory frameworks and healthcare practices is key; thus, an investment in regional market research can unveil opportunities to customize products and streamline distribution channels. Leaders are encouraged to foster strong alliances with local hospitals, research institutes, and specialty clinics to build a resilient network that is capable of addressing both acute and chronic conditions linked to portal hypertension, liver cirrhosis, and other liver-associated diseases.

On the operational front, implementing best practices in manufacturing and quality assurance can significantly reduce production costs while enhancing reliability. By leveraging automation and adopting standardized protocols across multiple facilities, companies can achieve economies of scale and ensure consistent device quality irrespective of the production location.

Lastly, a robust post-market surveillance system is crucial in maintaining safety and efficacy benchmarks. Industry players should invest in systems that facilitate rapid feedback from healthcare providers, enabling quick adjustments to device design and procedural protocols. This proactive approach not only improves patient outcomes but enhances market reputation, supporting long-term brand loyalty and trust among medical professionals.

Collectively, these actionable strategies serve as a roadmap for leaders intent on not just maintaining relevance but also in spearheading innovation and operational excellence in the TIPS market.

Conclusion: Steering the Future of TIPS Interventions

In conclusion, the market for transjugular intrahepatic portosystemic shunt procedures is marked by dynamic changes that are rapidly redefining clinical practices and market structures. This comprehensive analysis has highlighted the significance of robust segmentation strategies, regional market trends, and competitive insights that together provide a holistic view of the industry landscape.

Innovation remains the cornerstone of progress in the TIPS market, with technological breakthroughs in accessory devices, stent designs, and procedural protocols playing a pivotal role in enhancing patient care. The evolution of both elective and emergency shunt procedures underscores a shift as stakeholders are increasingly focusing on precision, safety, and adaptability.

Strategic collaborations among industry leaders and continuous investments in R&D signal a future where high-performance devices become the norm. The dynamic interplay of market segmentation factors-from product types and material compositions to procedural approaches and end-user engagements-offers a detailed map for navigating the challenges and opportunities in this evolving space.

The insights presented herein empower decision-makers with the necessary tools to forge ahead in a competitive environment. By embracing innovation, improving operational efficiencies, and aligning with regional and global market trends, industry players can confidently steer the future of TIPS interventions toward enhanced clinical outcomes and sustained market growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of liver diseases such as cirrhosis and portal hypertension
      • 5.1.1.2. Increasing adoption of minimally invasive surgical procedures due to faster recovery times
    • 5.1.2. Restraints
      • 5.1.2.1. Safety concerns and potential complications associated with intrahepatic portosystemic shunt procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing personalized TIPS treatment plans leveraging artificial intelligence for better patient outcomes
      • 5.1.3.2. Capitalizing on technological advancements in materials to enhance TIPS device efficacy and safety
    • 5.1.4. Challenges
      • 5.1.4.1. Insufficient insurance coverage and reimbursement issues related to TIPS procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising need for accessory devices for minimally invasive surgical procedures
    • 5.2.2. Application: Increasing necessity for TIPS procedure for curing portal hypertension
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transjugular Intrahepatic Portosystemic Shunt Market, by Product Type

  • 6.1. Introduction
  • 6.2. Accessory Devices
    • 6.2.1. Balloon Expanders
    • 6.2.2. Catheters
    • 6.2.3. Guiding Wires
  • 6.3. Stents
    • 6.3.1. Bare Metal Stents
    • 6.3.2. Drug-Eluting Stents
    • 6.3.3. Sectional Stents

7. Transjugular Intrahepatic Portosystemic Shunt Market, by Procedure Type

  • 7.1. Introduction
  • 7.2. Elective Shunts
  • 7.3. Emergency Shunts

8. Transjugular Intrahepatic Portosystemic Shunt Market, by Material Type

  • 8.1. Introduction
  • 8.2. Metallic Stents
  • 8.3. Polymers

9. Transjugular Intrahepatic Portosystemic Shunt Market, by Application

  • 9.1. Introduction
  • 9.2. Budd-Chiari Syndrome
  • 9.3. Hepatitis C
  • 9.4. Liver Cirrhosis
  • 9.5. Portal Hypertension

10. Transjugular Intrahepatic Portosystemic Shunt Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Hospitals
  • 10.4. Research Institutes
  • 10.5. Specialty Clinics

11. Americas Transjugular Intrahepatic Portosystemic Shunt Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Transjugular Intrahepatic Portosystemic Shunt Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Transjugular Intrahepatic Portosystemic Shunt Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Argon Medical enhances TIPS procedure with innovative liver management devices
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AngioDynamics Inc.
  • 2. Argon Medical Devices, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Boston Scientific Corporation
  • 5. Cook Group Incorporated
  • 6. Medtronic
  • 7. Merit Medical Systems, Inc.
  • 8. Siemens Healthcare Limited
  • 9. Sirtex Medical Inc.
  • 10. Terumo Medical Corporation
  • 11. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET MULTI-CURRENCY
  • FIGURE 2. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET MULTI-LANGUAGE
  • FIGURE 3. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET RESEARCH PROCESS
  • FIGURE 4. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BALLOON EXPANDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY GUIDING WIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY SECTIONAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ELECTIVE SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY EMERGENCY SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BUDD-CHIARI SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PORTAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)

T